HERA

Jan 24 2025HEALTH

Why Occupational Therapists Face Challenges in Mental Health Settings

Occupational therapists are well-versed in the importance of occupation in patient care, but they often face hurdles when trying to implement occupation-based practices. One significant barrier they encounter is hegemony — the influence of one group's ideas over others. In mental health settings, th

reading time less than a minute
Jan 24 2025SCIENCE

Beating Biologic Resistance: A New Nanovaccine Approach

Imagine you're taking medicine that your body refuses to accept because it mistakenly thinks it's an invader. This is a big problem in biologic therapies, where medicines like enzymes and gene therapies can trigger unwanted immune responses, making them less effective. Scientists are tackling this i

reading time less than a minute
Jan 23 2025HEALTH

Digital Medicine: A New Player in Europe's Healthcare

Digital therapeutics, or DTx, is a hot topic in the scientific world, drawing attention from all over. This review dives into what DTx is and how it can help treat various diseases, comparing it to traditional drug treatments. It also looks at the good and bad parts of the current European laws on D

reading time less than a minute
Jan 23 2025HEALTH

Boosting Ovarian Cancer Treatment with Nanoparticles

Imagine a tiny team of heroes fighting cancer. That's what scientists have created with manganese-based nanoparticles (let's call them MNP) and platinum-based nanoparticles (PnP). These tiny warriors activate a special pathway called cGAS-STING in the body, which helps the immune system fight back.

reading time less than a minute
Jan 23 2025HEALTH

Choosing the Right Second-Line Chemo for Advanced Biliary Cancer

When facing advanced biliary tract cancer (BTC), patients often need second-line chemotherapy after the first treatment fails. This review digs into the available evidence to help doctors and patients make informed choices. By comparing different chemo options using a method called network meta-anal

reading time less than a minute
Jan 23 2025HEALTH

How Lymphocyte Immunotherapy Affects Fertility in Women with Recurrent Pregnancy Loss

Imagine you're trying to have a baby but keep losing pregnancies. Doctors call this recurrent pregnancy loss (RPL). Some women with RPL have antinuclear antibodies (ANA) in their blood. Scientists wanted to see if a treatment called lymphocyte immunotherapy (LIT) could help these women. They studied

reading time less than a minute
Jan 23 2025HEALTH

Neuropathy Risk: A Year with Chemo Drugs

Did you know that chemotherapy can sometimes cause nerve damage in your hands and feet? This is called peripheral neuropathy, and it can really affect how patients feel and live their lives. A big study called the MiroCIP study looked into this. They checked out two types of chemo drugs: oxaliplatin

reading time less than a minute
Jan 23 2025HEALTH

Hands-On Innovation: A Flexible, Wearable Sensor That Boosts Human Touch

You know those virtual reality gloves that make you feel like you're holding an object? Well, imagine a wearable device that's designed to directly interact with your nerves by mimicking touch. Researchers have created a clever little platform that uses advanced manufacturing techniques to combine c

reading time less than a minute
Jan 23 2025HEALTH

Combining Compression and Exercise to Beat Chemo's Nerve Numbness

Ever wondered if squeezing and moving could help beat the nerve pain from breast cancer chemo? Researchers did, and they found out something interesting. They gathered people who had numbness in their hands and feet from chemo, and split them into two groups. One group tried combining squeezing (com

reading time less than a minute
Jan 22 2025SCIENCE

Unlocking the Power of UGT51: A New Way to Produce Rare Ginsenoside Rh2

You might have heard of ginsenoside Rh2, a compound with amazing health benefits. It can help fight certain cancers, reduce inflammation, and even tackle diabetes. But how do we make more of this wonder substance? Scientists have been looking into an enzyme called UGT51 from yeast, which plays a key

reading time less than a minute